A kit method for the high level synthesis of [211At]MABG
- 15 May 2007
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 15 (10), 3430-3436
- https://doi.org/10.1016/j.bmc.2007.03.016
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Malignant Pheochromocytoma in a Population-Based Study: Survival and Clinical ResultsAnnals of the New York Academy of Sciences, 2006
- Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium StudyJournal of Clinical Oncology, 2006
- An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effectsThe Journal of Gene Medicine, 2004
- High‐dose 131I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytomaCancer, 2003
- Treatment of Neuroendocrine Tumours in Adults with 131I-MIBG TherapyClinical Oncology, 2003
- Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft modelNuclear Medicine and Biology, 1996
- Meta-[131I]iodobenzylguanidine uptake andmeta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell linesJournal of Neuro-Oncology, 1995
- (4-[18F]Fluoro-3-iodobenzyl)guanidine, a Potential MIBG Analog for Positron Emission TomographyJournal of Medicinal Chemistry, 1994
- Meta‐[211AT]astatobenzylguanidine: Further evaluation of a potential therapeutic agentInternational Journal of Cancer, 1994
- Preparation and pharmacological characterization of [76Br]-meta-bromobenzylguanidine ([76Br]MBBG)Nuclear Medicine and Biology, 1994